GLAZER CAPITAL, LLC - BIOPLUS ACQUISITION CORP ownership

BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217117. A total of 67 filers reported holding BIOPLUS ACQUISITION CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GLAZER CAPITAL, LLC ownership history of BIOPLUS ACQUISITION CORP
ValueSharesWeighting
Q3 2023$3,334
+1.6%
307,532
-0.2%
0.22%0.0%
Q2 2023$3,281
+100.9%
308,120
+97.0%
0.22%
+143.8%
Q1 2023$1,633
-5.0%
156,413
-6.8%
0.09%
+102.3%
Q4 2022$1,719
-99.9%
167,915
+9.4%
0.04%
+57.1%
Q3 2022$1,538,000
+0.1%
153,467
-0.4%
0.03%
-26.3%
Q2 2022$1,537,000
+32.2%
154,058
+30.9%
0.04%
+15.2%
Q1 2022$1,163,000117,6760.03%
Other shareholders
BIOPLUS ACQUISITION CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 66,607$6851.08%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 1,482,836$15,2440.42%
MMCAP International Inc. SPC 400,000$4,088,0000.42%
CANTOR FITZGERALD, L. P. 1,422,204$14,5570.31%
KIM, LLC 500,000$5,1400.28%
Spartan Fund Management Inc. 74,485$7630.28%
Saba Capital Management, L.P. 1,791,845$18,384,3300.25%
Atalaya Capital Management LP 125,000$1,285,0000.23%
Radcliffe Capital Management, L.P. 555,355$5,697,9420.18%
Exos TFP Holdings LLC 62,500$638,7500.18%
View complete list of BIOPLUS ACQUISITION CORP shareholders